APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Popular cities in Kansas
With a well-established healthcare network and renowned medical research institutions, Kansas has emerged as a significant hub for a wide range of clinical trials. Leading institutions such as The University of Kansas Medical Center, Wesley Medical Center, and Children's Mercy Kansas City are at the forefront of groundbreaking studies.
These centers are recognized for their contributions to innovative medical research, helping to advance treatments in fields such as oncology, cardiology, and pediatrics.
Why choose Kansas for clinical trials?
Kansas offers unique advantages for those participating in clinical trials. The state’s central location, combined with a mix of urban and rural populations, provides a diverse range of participants, making research findings more comprehensive and applicable to various communities. Kansas is also known for its collaborative research environment, where major institutions work closely with local healthcare providers to drive medical advancements.
By participating in a clinical trial in Kansas, volunteers contribute to critical research efforts while benefiting from a supportive, patient-focused clinical research system that emphasizes innovation and community engagement.
Common conditions studied in Kansas
Kansas plays a crucial role in clinical research, focusing on several key medical conditions that not only affect local populations but also contribute to global advancements in healthcare.
Neurological Disorders
Researchers in Kansas focus on both pharmacological treatments and lifestyle interventions, such as diet and exercise, when it comes to neurological research and slowing the progression of these diseases. With neurodegenerative diseases becoming more prevalent due to aging populations, the research conducted in Kansas is crucial for shaping future therapies and preventive measures.
The University of Kansas Alzheimer’s Disease Research Center (KU ADRC) is a leader in exploring the causes and potential treatments for Alzheimer’s disease, dementia, and other neurological disorders like Parkinson’s and multiple sclerosis (MS). Kansas has earned a reputation in the medical community for its clinical trials on cognitive decline and brain aging.
Diabetes and metabolic disorders
The Midwest, including Kansas, has some of the highest rates of Type 2 diabetes, which makes the state a critical location for diabetes research. Clinical trials in Kansas explore a variety of approaches to managing both Type 1 and Type 2 diabetes, including new drug therapies, insulin delivery methods, and interventions to prevent complications such as neuropathy and cardiovascular damage.
Institutions like The University of Kansas Medical Center and Wesley Medical Center are involved in large-scale studies that investigate how metabolic disorders can be better managed and potentially reversed through innovative therapies. These trials are crucial as diabetes continues to rise, both in Kansas and globally.
Rare diseases and pediatric research
Kansas is renowned for its research efforts in rare diseases and pediatric research. In particular, Children’s Mercy Kansas City is internationally recognized for its focus on rare diseases and pediatric conditions. It leads numerous clinical trials in targeting genetic and metabolic disorders that are often under-researched due to their rarity. For example, the hospital is involved in trials for cystic fibrosis, Duchenne muscular dystrophy, and rare autoimmune disorders.
Children’s Mercy has also developed a strong reputation for using genomics to tailor treatments for children with complex health conditions. Kansas’ contributions to rare disease research are pivotal, as they often provide new hope for children and families facing conditions for which there are limited treatment options.
Cancer
In Kansas, researchers place a strong focus on early detection, personalized medicine, and immunotherapy, placing Kansas at the cutting edge of oncology research. The University of Kansas Cancer Center (KUCC) is one of only 72 National Cancer Institute-designated cancer centers in the U.S., recognized for its excellence in research, prevention, and treatment.
KUCC is known for groundbreaking studies in breast, prostate, leukemia, lung, and colorectal cancer, which are among the most prevalent cancers in the region. The work conducted at KUCC has helped improve treatment protocols and survival rates for patients, not just in Kansas but worldwide, by leading clinical trials for new therapies and drugs.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Cardiovascular disease
Kansas is home to some of the nation’s leading cardiovascular research programs, particularly through partnerships with hospitals like The University of Kansas Medical Center and Stormont Vail Health. Clinical trials focus on heart failure, atrial fibrillation, hypertension, and innovative procedures such as minimally invasive valve replacements.
Kansas is also heavily involved in studying preventative measures for heart disease, stroke recovery, and cardiac rehabilitation, helping to develop advanced treatment methods and lifestyle interventions. Given that heart disease is one of the leading causes of death in the U.S., Kansas’ contributions to cardiovascular research are vital for improving health outcomes across the nation.
Local regulations and guidelines
Clinical trials in Kansas are governed by both federal and state regulations that protect participants and ensure ethical research practices. Oversight is primarily provided by the FDA and Institutional Review Boards (IRBs), which ensure compliance with federal standards like Good Clinical Practice (GCP) and informed consent requirements.
Kansas-specific regulations, including state statutes on human research, also contribute to ensuring trials are conducted ethically and safely. Key medical research institutions follow strict protocols to protect vulnerable populations, such as children and individuals with cognitive impairments while safeguarding participants' privacy through HIPAA and local privacy laws.
Benefits of participating in clinical trials
Joining a clinical trial gives individuals the chance to explore new, innovative treatments and therapies that may not yet be available to the public. This is particularly beneficial for those with conditions that haven’t responded to conventional care or currently available treatments. Participants receive specialized attention from medical professionals who monitor their health closely to ensure both safety and treatment effectiveness.
Beyond personal benefits, clinical trial participation plays a crucial role in advancing medical science. By taking part, individuals help drive the development of new treatments and contribute to improving healthcare outcomes worldwide. This involvement can lead to breakthroughs that shape the future of medicine and offer hope to countless patients.
How to enroll in a clinical trial in Kansas
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.